Alpha-1-antitrypsin deficiency
1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Characteristics of individuals with alpha-1 antitrypsin deficiency from Northern and Southern European countries : EARCO international registry
(
- Contribution to journal › Letter
- 2022
-
Mark
The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening
(
- Contribution to journal › Article
-
Mark
Triglyceride-Glucose Index is a Risk Marker of Incident COPD Events in Women
(
- Contribution to journal › Article
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency: the importance of early identification
(
- Contribution to journal › Article
-
Mark
Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency : EARCO international registry
(
- Contribution to journal › Article
-
Mark
Low Prevalence of Mild Alpha-1-Antitrypsin Deficiency in Hospitalized COVID-19-Patients
(
- Contribution to journal › Article
-
Mark
Impact of COVID-19 in Patients With Severe Alpha-1 Antitrypsin Deficiency : The IMCA1 Study of the EARCO Clinical Research Collaboration
(
- Contribution to journal › Letter
-
Mark
Cancer risk in severe alpha-1-antitrypsin deficiency
(
- Contribution to journal › Article
- 2021
-
Mark
Severe alpha-1-antitrypsin deficiency increases the risk of venous thromboembolism
(
- Contribution to journal › Article
-
Mark
Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42
(
- Contribution to journal › Article